The tuberculosis treatment success rate for previously treated cases in China stood at 84 units in 2023. Over the past years, there have been fluctuations, with a peak of 90 units in 2013 and a low of 81 units in 2016 and 2018. The year-on-year variation over the last two years has indicated stability, keeping at 84 units between 2023 and the forecasted 2024. The 5-year CAGR from 2023 to 2028 is forecasted to be -0.24%, indicating a slight decline. Over the five-year period forecast until 2028, the average annual growth rate is projected to decrease by -1.19%.
Future trends to watch for include potential advancements in medical treatments and healthcare policies that could impact the success rate. Additionally, monitoring developments in public health initiatives and technology innovations will be crucial in understanding their potential effects on the treatment outcomes.
